Macrolides, lincosamides and streptogramins hospital use Europe 2023

Hospital consumption of macrolides for systemic use in Europe in 2023, by country (in DDD per 1,000 inhabitants per day)

Macrolides, lincosamides and streptogramins systemic use: consumption in Europe 2023

Last update:

Nov 20, 2024

Author:

��ƽ�� Research Department

Region:

Europe

Survey time period:

From 01/01/2023 to 31/12/2023

This statistic displays the hospital consumption of macrolides, lincosamides and streptogramins (J01F) for systemic use in Europe in 2023, by country. The defined daily dose (DDD) of macrolides, lincosamides, and streptogramins per 1,000 inhabitants per day in the hospital sector in Italy amounted to 0.17 in that year.

We’re happy to help

Get in touch with us for additional information

Feel free to contact us anytime. We will respond to your inquiry as quickly as possible.

Get in touch

�����ƽ��

Hospital consumption of macrolides for systemic use in Europe in 2023, by country (in DDD per 1,000 inhabitants per day)

Get in touch with us for additional information

��ƽ��